Goodbody Health Limited
GDBYF · OTC
12/31/2021 | 12/31/2020 | 12/31/2019 | 7/31/2018 | |
|---|---|---|---|---|
| Revenue | $17,058 | $1,994 | $1,449 | $452 |
| % Growth | 755.5% | 37.6% | 220.3% | – |
| Cost of Goods Sold | $8,127 | $871 | $695 | $0 |
| Gross Profit | $8,931 | $1,124 | $754 | $0 |
| % Margin | 52.4% | 56.4% | 52% | 0% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $4,267 | $4,737 | $3,531 | $175 |
| SG&A Expenses | $8,484 | $5,277 | $4,003 | $175 |
| Sales & Mktg Exp. | $4,218 | $540 | $472 | $0 |
| Other Operating Expenses | $1,503 | $479 | -$3,248 | $0 |
| Operating Expenses | $9,987 | $5,769 | $754 | $175 |
| Operating Income | -$1,057 | -$4,466 | -$3,320 | -$176 |
| % Margin | -6.2% | -224% | -229.1% | -38.9% |
| Other Income/Exp. Net | -$1,189 | -$196 | -$478 | $12 |
| Pre-Tax Income | -$2,246 | -$4,787 | -$3,798 | -$349 |
| Tax Expense | $68 | -$129 | $0 | $1 |
| Net Income | -$2,314 | -$4,659 | -$3,798 | -$349 |
| % Margin | -13.6% | -233.7% | -262.1% | -77.1% |
| EPS | -0.067 | -0.29 | -0.48 | -0.17 |
| % Growth | 76.9% | 39.6% | -182.4% | – |
| EPS Diluted | -0.067 | -0.29 | -0.48 | -0.17 |
| Weighted Avg Shares Out | 34,618 | 16,245 | 7,960 | 35,801 |
| Weighted Avg Shares Out Dil | 34,618 | 16,245 | 7,960 | 35,801 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $64 | $0 | $0 |
| Interest Expense | $13 | $27 | $11 | $1 |
| Depreciation & Amortization | $1,043 | $471 | $260 | $0 |
| EBITDA | -$14 | -$4,120 | -$3,293 | -$175 |
| % Margin | -0.1% | -206.6% | -227.3% | -38.7% |